Background: Postpartum is a highly vulnerable time for women with opioid use disorder
(OUD). Our primary objective was to identify patient and provider reported aspects of the …

Introduction: Opioid overdose has become a leading cause of pregnancy-associated deaths,
particularly in the 1st year postpartum, highlighting the need to better understand how to …

Background Opioid use disorder (OUD) is associated with substantial morbidity and
mortality for women, especially during the perinatal period. Opioid overdose has become a …

Introduction Medications to treat opioid use disorder (MOUD) during pregnancy and in the
postpartum period remain underutilized. A need exists to enhance our understanding of …

Background Pregnancy and the delivery of an infant mark a unique time of engagement in
healthcare for women in treatment for opioid use disorder (OUD). The American College of …

Introduction The current opioid crisis and associated heroin epidemic have exhausted the
limited community services that are available to substance users, with only about 12% of …

Issues Addressing opioid use disorder (OUD) among pregnant women is of growing
importance, and substance use treatment positively impacts outcomes for mother and baby …

Objective To evaluate the impact of women-centered substance abuse treatment
programming on outcomes among pregnant women with opioid use disorder (OUD) …

Background and Objectives The factors associated with medication for opioid use disorder
(MOUD) treatment retention among pregnant women with opioid use disorder (OUD) are …

Objective This study describes the experience of pregnancy and childbirth from the
perspective of women with opioid use disorder. Methods This qualitative study analyzed …